CAS 883715-18-2

Formula: C25H37NO

InChI: InChI=1S/C25H37NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-25(27)26-23-24-20-17-16-18-21-24/h3-4,6-7,9-10,16-18,20-21H,2,5,8,11-15,19,22-23H2,1H3,(H,26,27)/b4-3-,7-6-,10-9-

InChI key: VCMMYRWIEZCYDK-PDBXOOCHSA-N

SMILES: CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)NCC1=CC=CC=C1

N-Benzyllinolenamide

CAS: 883715-18-2

N-Benzyllinolenamide

Formula: C₂₅H₃₇NO

Purity: 99.5%

Molecular weight: 367.57

Ref: 54-BUP07070

N-Benzyllinolenamide

CAS: 883715-18-2

Formula: C₂₅H₃₇NO

Molecular weight: 367.58

Ref: 7W-GY4702

N-Benzyllinolenamide

CAS: 883715-18-2

Formula: C₂₅H₃₇NO

Purity: 95%~99%

Molecular weight: 367.577

Ref: BP-SBP04343

N-Benzyllinolenamide

CAS: 883715-18-2

Formula: C₂₅H₃₇NO

Purity: 98%

Molecular weight: 367.5674

Ref: IN-DA00H1MA

N-​Benzyllinolenamide

CAS: 883715-18-2

N-Benzyllinolenamide is a natural product. It is an inhibitor of fatty acid amide hydrolase (FAAH, IC50 of 41.8 μM).

Formula: C₂₅H₃₇NO

Purity: 98.7% - 99.92%

Color and Shape: Solid

Molecular weight: 367.5674

Ref: TM-TN1965

N-benzyl-9Z,12Z,15Z-octadecatrienamide

CAS: 883715-18-2

N-benzyl-9Z,12Z,15Z-octadecatrienamide (NBDOT) is a cannabimimetic compound that was synthesized to investigate the role of mitochondria in neurodegenerative diseases. NBDOT binds to protein targets in the mitochondria and inhibits their function. This leads to an increase in free fatty acids and endocannabinoids, as well as potent inhibition of CB1 receptor activity. These activities have been demonstrated using in vivo studies on rats. NBDOT also has a potent inhibitory effect on fatty acid amide hydrolase, which is involved in the degradation of endocannabinoids.

Formula: C₂₅H₃₇NO

Purity: Min. 95%

Molecular weight: 367.57 g/mol

Ref: 3D-FB74463